Smeets Michel W J, Mourik Marjon J, Niessen Hans W M, Hordijk Peter L
From the Departments of Molecular Cell Biology (M.W.J.S., P.L.H.) and Plasma Proteins (M.J.M.), Sanquin-Academic Medical Center Landsteiner Laboratory, Amsterdam, The Netherlands; and Department of Pathology and Cardiac Surgery, ICaR-VU (H.W.M.N.) and Department of Physiology (P.L.H.), VU University Medical Center, Amsterdam, The Netherlands.
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1618-1627. doi: 10.1161/ATVBAHA.117.309885. Epub 2017 Aug 3.
Venous thromboembolism is a major contributor to global disease burden. Leukocytes and platelets initiate thrombogenesis on blood stasis and initiate the formation of a fibrin, VWF (von Willebrand factor), and neutrophil extracellular trap scaffold for erythrocytes. However, there is little knowledge on how erythrocytes become stably incorporated into this scaffold. Recently, we described the adhesion of calcium-loaded erythrocytes to endothelial-derived VWF strings. Because VWF is part of the scaffold of venous thrombi, we questioned whether reduced flow or stasis promotes the adhesion of normal erythrocytes to VWF and whether venous thrombi show evidence of erythrocyte-VWF interactions.
In the present work, we perfused, under controlled shear conditions, washed, normal erythrocytes over surface-immobilized plasma and extracellular matrix proteins and showed that normal erythrocytes specifically bind to VWF. The interaction between erythrocytes and VWF significantly increased when the wall shear stress was reduced. Next, we investigated whether erythrocyte-VWF interactions support the structure of venous thrombi. High-resolution immunofluorescence imaging of human venous thrombi showed a striking pattern between erythrocytes, VWF, and fibrin, which suggests that VWF plays a supporting role, linking erythrocytes to fibrin in the thrombus.
Our data suggest that erythrocyte retention in venous thrombi is mediated by erythrocyte-VWF or erythrocyte-VWF-fibrin interactions. Targeting erythrocyte retention could be a new strategy in the treatment or prevention of venous thrombosis.
静脉血栓栓塞是全球疾病负担的主要促成因素。白细胞和血小板在血液淤滞时启动血栓形成,并启动纤维蛋白、血管性血友病因子(VWF)和中性粒细胞胞外陷阱支架的形成,以供红细胞附着。然而,关于红细胞如何稳定地整合到这个支架中,我们知之甚少。最近,我们描述了钙负载的红细胞与内皮衍生的VWF链的粘附。由于VWF是静脉血栓支架的一部分,我们质疑血流减少或淤滞是否会促进正常红细胞与VWF的粘附,以及静脉血栓是否显示出红细胞与VWF相互作用的证据。
在本研究中,我们在可控剪切条件下,将洗涤后的正常红细胞灌注到表面固定的血浆和细胞外基质蛋白上,结果显示正常红细胞能特异性结合VWF。当壁面剪切应力降低时,红细胞与VWF之间的相互作用显著增加。接下来,我们研究了红细胞与VWF的相互作用是否支持静脉血栓的结构。对人静脉血栓的高分辨率免疫荧光成像显示,红细胞、VWF和纤维蛋白之间呈现出一种显著的模式,这表明VWF起到了支持作用,将血栓中的红细胞与纤维蛋白连接起来。
我们的数据表明,静脉血栓中红细胞的滞留是由红细胞与VWF或红细胞与VWF - 纤维蛋白的相互作用介导的。针对红细胞滞留可能是治疗或预防静脉血栓形成的一种新策略。